SEYİTLER KİMYA SANAYİ A.Ş. Logo

SEYİTLER KİMYA SANAYİ A.Ş.

Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.

SEYKM | IS

Overview

Corporate Details

ISIN(s):
TRESEYT00011 (+2 more)
LEI:
789000QODBWOP1OPEQ85
Country:
Türkiye
Address:
Turgutlu 1. OSB 2007 Cad. No:5-7 Turgutlu, 45400 MANİSA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Established in 1991, Seyitler Kimya Sanayi A.Ş. is a leading manufacturer in the healthcare sector. The company specializes in producing a range of medical supplies, including medical adhesive tapes, wound dressings, first aid plasters, and capsicum rheumatism plasters. With a focus on quality management and continuous research and development, Seyitler Kimya aims to serve the healthcare industry by providing reliable products. The company's goal is to be a preferred manufacturer both in its domestic market and globally, driven by a commitment to customer satisfaction and high production standards.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 17:03
Audit Report / Information
Bağımsız Denetim Kuruluşunun Belirlenmesi
Turkish 29.1 KB
2025-09-29 17:02
Pre-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 364.0 KB
2025-09-29 17:02
Proxy Solicitation & Information Statement
Genel Kurul Tescili Hk.
Turkish 179.5 KB
2025-09-29 17:02
Pre-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 190.1 KB
2025-09-29 17:02
Pre-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 116.4 KB
2025-09-29 17:02
Post-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 684.5 KB
2025-09-29 17:02
Board/Management Information
Genel Kurul Tescili Hk.
English 154.2 KB
2025-09-29 17:02
Pre-Annual General Meeting Information
Genel Kurul Tescili Hk.
Turkish 28.9 KB
2025-09-26 16:30
Notice of Dividend Amount
Kar Payı Dağıtımı Hk.
Turkish 266.3 KB
2025-09-26 16:30
Notice of Dividend Amount
Kar Payı Dağıtımı Hk.
English 24.3 KB
2025-09-26 16:13
Pre-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Toplantı Sonucu Hk.
Turkish 364.0 KB
2025-09-26 16:13
Proxy Solicitation & Information Statement
2024 Yılı Olağan Genel Kurul Toplantı Sonucu Hk.
Turkish 179.5 KB
2025-09-26 16:13
Pre-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Toplantı Sonucu Hk.
Turkish 190.1 KB
2025-09-26 16:13
Pre-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Toplantı Sonucu Hk.
Turkish 116.4 KB
2025-09-26 16:13
Post-Annual General Meeting Information
2024 Yılı Olağan Genel Kurul Toplantı Sonucu Hk.
Turkish 684.5 KB

Automate Your Workflow. Get a real-time feed of all SEYİTLER KİMYA SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for SEYİTLER KİMYA SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.